The DOI matches its Crossref record.
Effect of Insulin and Glucose Infusions on Sympathetic Nervous System Activity in Normal Man
Abstract
Recent studies indicate a link between carbohydrate intake and the functional state of the sympathetic nervous system. Fasting or carbohydrate restriction decreases sympathetic activity, while glucose ingestion or dietary supplementation with sucrose increases sympathetic nerve activity. To examine the potential contributions of hyperglycemia and hyperinsulinemia to sympathetic stimulation, sympathetic activity was assessed by measurement of plasma norepinephrine (NE) levels and concomitant cardiovascular indices in nonobese young men during glucose and insulin infusions using glucose clamp techniques. In the insulin infusion studies (euglycemic glucose clamp), insulin was administered at 2 mU/kg/min and 5 mU/kg/min for 2 h while blood glucose was maintained at basal levels by a variable rate of glucose infusion. In the hyperglycemic studies, blood glucose was raised 125 mg/dl above basal and maintained at that level for 2h. In response to both insulin infusions, plasma NE rose progressively over the course of the study, increasing 50% with the 2-mU infusion (from mean basal value of 240 ± 34 pg/ml to 360 ± 41 at 150 min, P < 0.001 for changes over time by analysis of variance) and 117% with the 5-mil infusion (from 254 ± 20 pg/ml to 551 ± 88 at 150 min, P < 0.001). The plasma NE response was greater with the 5-mll than with the 2-mU insulin infusion (P < 0.001), and similarly, was greater during the 2-mU insulin infusion than during a control test in which neither insulin nor glucose was infused (P < 0.001). Associated with the elevations in plasma NE In the 2-mU insulin infusion were increases in pulse rate (P < 0.05), pulse pressure (P < 0.005), and pulse rate - systolic blood pressure product (P < 0.01), and during the 5-mU insulin infusions there were increases in pulse pressure (P < 0.001), mean arterial blood pressure (P < 0.001), and pulse rate - systolic blood pressure product (P < 0.001). Plasma NE did not change during the hyperglycemic glucose clamp nor during control tests, and pulse pressure in the hyperglycemic studies (P < 0.005) was the only cardiovascular measurement increased by these two infusion protocols. The clearance of NE in three subjects was unaffected by the 2-mU insulin infusion. Thus, insulin infusion increases sympathetic nervous system activity in the absence of changes in blood glucose.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the present study, infusion of exogenous glucose in amounts comparable to those used in this earlier study (26) also did not increase plasma norepinephrine levels significantly, but evoked highly significant increases in sympathetic discharge targeted at skeletal muscle.”
From Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans (1993) · cites this paper as [26]
In the citing paper
“However, the conclusions of one study were based upon the absence of a detectable effect of glucose infusion on plasma norepinephrine levels (5, 26), a relatively insensitive index of sympathetic discharge (34–36).”
From Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans (1993) · cites this paper as [26]
In the citing paper
“Second, a balance between insulin's opposing sympathoexcitatory pressor and vasodilatory depressor effects may offer a potential explanation for the present, and earlier (6, 7, 26) observations, that in lean healthy subjects acute hyperinsulinemia at high physiologic concentrations does not raise arterial pressure.”
From Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans (1993) · cites this paper as [26]
In the citing paper
“Since insulin stimulates the sympathetic nervous system (SNS), 16,17 and since obese patients have increased SNS activity, [18][19][20] a role for insulin-mediated SNS stimulation seems a likely factor in the pathogenesis of high BP in the setting of central obesity.”
Citations
Cited by
Sorted by citations
Items 301–400 of 995
Hyperglycemia affects cardiovascular autonomic nerve function in normal subjects
Yeap, B. B., Russo, A., Fraser, R. J., Wittert, G., & Horowitz, M. (1996) · Diabetes Care · doi:10.2337/diacare.19.8.880 · Cited by 62
“The increase in resting heart rate during hyperglycemia is also unlikely to reflect an increase in plasma catecholamine concentrations (11).”
BackgroundThe effect of intrahypothalamic injections of glucose on sympathetic efferent firing rate
Sakaguchi, T., & Bray, G. A. (1987) · Brain Research Bulletin · doi:10.1016/0361-9230(87)90128-6 · Cited by 63
Felten, S. Y., Peterson, R. G., Shea, P. A., Besch, H. R., & Felten, D. L. (1982) · Brain Research Bulletin · doi:10.1016/0361-9230(82)90086-7 · Cited by 62
Cephalic postprandial thermogenesis in human subjects
LEBLANC, J., & Cabanac, M. (1989) · Physiology & Behavior · doi:10.1016/0031-9384(89)90024-3 · Cited by 62
Glucose ingestion affects cardiac ANS in healthy subjects with different amounts of body fat.
Paolisso, G., Manzella, D., Ferrara, N., Gambardella, A., Abete, P., Tagliamonte, M. R., Lucia, D. D., Furgi, G., Picone, C., Gentile, S., et al. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.273.3.e471 · Cited by 61
Acute effects of insulin on cardiovascular function and noradrenaline uptake and release
Christensen, N. J. (1983) · Diabetologia · doi:10.1007/bf00282513 · Cited by 62
“The rise in plasma NA after insulin does not depend on reduction of blood glucose concentration [8, 13].”
InfluentialInsulin resistance and blood pressure regulation in obese and nonobese subjects. Special lecture.
Rocchini, A. P. (1991) · Hypertension · doi:10.1161/01.hyp.17.6.837 · Cited by 62
Pentobarbital reduces basal liver glucose output and its insulin suppression in rats
Clark, P. W., Jenkins, A. B., & Kraegen, E. W. (1990) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1990.258.4.e701 · Cited by 62
Contribution of salt intake to insulin resistance associated with hypertension
Ogihara, T., Asano, T., & Fujita, T. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00315-1 · Cited by 60
Therapy with insulin in cardiac surgery: controversies and possible solutions
Doenst, T., Bothe, W., & Beyersdorf, F. (2003) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(02)04698-2 · Cited by 60
Influence of Sex and Obesity on Plasma Catecholamine Response to Isometric Exercise*
Gustafson, A. B., & Kalkhoff, R. K. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-55-4-703 · Cited by 60
An association between hyperinsulinemia and hypertension during the third trimester of pregnancy
Bauman, W. A., Maimen, M., & Langer, O. (1988) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(88)80105-4 · Cited by 59
Insulin, Neuropeptide Y, and Food Intake
Schwartz, M. W., Figlewicz, D. P., Woods, S. C., Porte, D., & Baskin, D. G. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb26206.x · Cited by 59
The edematogenic properties of insulin
Kalambokis, G. N., Tsatsoulis, A. A., & Tsianos, E. V. (2004) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2004.06.025 · Cited by 74
Gans, R. O. B., Bilo, H. J. G., MAARSCHALKERWEERD, W. W. A. V., Heine, R. J., Nauta, J. J. P., & Donker, A. J. M. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115333 · Cited by 57
Weissman, A., Lowenstein, L., Peleg, A., Thaler, I., & Zimmer, E. Z. (2006) · Diabetes Care · doi:10.2337/diacare.29.03.06.dc05-2009 · Cited by 57
Disparity of autonomic control in type 2 diabetes mellitus
Huggett, R. J., SCOTT, E. M., Gilbey, S. G., Bannister, J., Mackintosh, A., & Mary, D. A. S. G. (2004) · Diabetologia · doi:10.1007/s00125-004-1601-6 · Cited by 56
Abdulla, M. H., Sattar, M. Z. A., & Johns, E. J. (2011) · International Journal of Nephrology · doi:10.4061/2011/934659 · Cited by 57
Watanabe, K., Sekiya, M., Tsuruoka, T., Funada, J., & Kameoka, H. (1999) · Journal of Hypertension · doi:10.1097/00004872-199917080-00015 · Cited by 57
Role of Insulin-Mediated Antinatriuresis in Sodium Homeostasis and Hypertension
Brands, M. W. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.11728 · Cited by 56
Frontoni, S., Bracaglia, D., Baroni, A., Pellegrini, F., Perna, M., Cicconetti, E., Ciampittiello, G., Menzinger, G., & Gambardella, S. (2003) · Hypertension · doi:10.1161/01.hyp.0000073062.29546.01 · Cited by 56
Relations of Insulin Sensitivity to Longitudinal Blood Pressure Tracking
Ärnlöv, J., Pencina, M. J., Nam, B., Meigs, J. B., Fox, C. S., Levy, D. A., D’Agostino, R. B., & Vasan, R. S. (2005) · Circulation · doi:10.1161/circulationaha.105.535039 · Cited by 55
Pressor doses of angiotensin II increase insulin-mediated glucose uptake in normotensive men.
Townsend, R. R., & DiPette, D. (1993) · American Journal of Physiology · doi:10.1152/ajpendo.1993.265.3.e362 · Cited by 62
Jansen, R. W. M. M., Peeters, T. L., van Lier, H. J. J., & Hoefnagels, W. H. L. (1990) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1990.tb02268.x · Cited by 56
Trovati, M., Massucco, P., Mattiello, L., Cavalot, F. L., Mularoni, E., Hahn, A., & Anfossi, G. (1995) · Diabetologia · doi:10.1007/bf00400582 · Cited by 57
“This suggestion is supported by observations that insulin induces sodium reabsorption [2], stimulates catecholamine release and activates the sympathetic nervous system [3-5], increases renin and angiotensin II production [6], enhances plasma endothelin-1 concentrations [7] and its release from both vascular endotheli…”
BackgroundEffects of dietary carbohydrate, fat, and protein on norepinephrine turnover in rats
Tuig, J. G. V., & Romsos, D. R. (1984) · Metabolism · doi:10.1016/0026-0495(84)90158-6 · Cited by 56
Glucose tolerance and insulin action in rats with renovascular hypertension.
Buchanan, T. A., Sipos, G. F., Gadalah, S., Yip, K., Marsh, D. J., Hsueh, W. A., & Bergman, R. N. (1991) · Hypertension · doi:10.1161/01.hyp.18.3.341 · Cited by 55
“-(31) The mechanism responsible for the association between blood pressure and insulin in normal animals is not apparent from the present study but could reflect the effects of insulin on renal sodium handling(12)-(14) or sympathetic nervous system activity.(15)-(17) The lack of a significant insulin-blood pressure re…”
BackgroundBisquolo, V. A. F., Cardoso, C. G., Ortega, K. C., Gusmão, J. L., Tinucci, T., Negrão, C. E., Wajchenberg, B. L., Mion, D., & Forjaz, C. L. M. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00251.2004 · Cited by 54
“However, previous studies (6, 16, 30) have already stated that vehicle infusion does not promote time-dependent changes in MSNA, FBF, HR, and BP.”
BackgroundAlizadeh, S., Ahmadi, M., Nejad, B. G., Djazayeri, A., & Shab‐Bidar, S. (2018) · International Journal of Clinical Practice · doi:10.1111/ijcp.13201 · Cited by 56
Hoffman, R. P., Hausberg, M., Sinkey, C. A., & Anderson, E. A. (1999) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(98)00019-1 · Cited by 55
Nesbitt, S. D. (1997) · American Journal of Hypertension · doi:10.1016/s0895-7061(97)00267-7 · Cited by 55
Consequences of the Increased Autonomic Nervous Drive in Hypertension, Heart Failure and Diabetes
Julius, M. (1998) · Blood Pressure · doi:10.1080/080370598438410-1 · Cited by 55
Pathogenesis of Hypertension in Diabetes
Stas, S. N., El-Atat, F. A., & Sowers, J. R. (2004) · Reviews in Endocrine and Metabolic Disorders · doi:10.1023/b:remd.0000032410.75638.da · Cited by 56
“Insulin infusion in euglycemic clamp conditions increases plasma norepinephrine and blood pressure in normal subjects [18].”
BackgroundObesity, blood pressure, and the sympathetic nervous system
Landsberg, L., Troisi, R. J., Parker, D. R., Young, J. B., & Weiss, S. T. (1991) · Annals of Epidemiology · doi:10.1016/1047-2797(91)90040-j · Cited by 54
Self-citationInsulin and hypertension: a causal relationship?
Bhanot, S., & McNeill, J. H. (1996) · Cardiovascular Research · doi:10.1016/s0008-6363(95)00218-9 · Cited by 54
Smits, M. M., Tonneijck, L., Muskiet, M. H. A., Hoekstra, T., Kramer, M. H. H., Diamant, M., & van Raalte, D. H. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-0507 · Cited by 54
Adenosine Actions are Preserved in Corpus Cavernosum from Obese and Type II Diabetic db/db Mouse
Carneiro, F. S., Giachini, F. R. C., Lima, V. V., Carneiro, Z. N., Leite, R., Inscho, E. W., Tostes, R. C., & Webb, R. C. (2008) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2007.00752.x · Cited by 53
Effect of experimental hyperinsulinemia on sympathetic nervous system activity in the rat
Young, J. B. (1988) · Life Sciences · doi:10.1016/0024-3205(88)90297-4 · Cited by 53
Self-citationAbnormalities of Insulin Receptors in Spontaneously Hypertensive Rats
Sechi, L. A., Griffin, C. A., Giacchetti, G., Zingaro, L., Catena, C., Bartoli, E., & Schambelan, M. (1996) · Hypertension · doi:10.1161/01.hyp.27.4.955 · Cited by 52
Jamerson, K., Smith, S., Amerena, J. V., Grant, E. J., & Julius, S. (1994) · Hypertension · doi:10.1161/01.hyp.23.6.1006 · Cited by 53
Hypertension in insulin-resistant Zucker obese rats is independent of sympathetic neural support
Zemel, M. B., Peuler, J. D., Sowers, J. R., et al. (1992) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1992.262.3.e368 · Cited by 53
Blunted norepinephrine responsiveness to changing energy states in obese subjects
Bazelmans, J., Nestel, P. J., O'Dea, K., & Esler, M. D. (1985) · Metabolism · doi:10.1016/0026-0495(85)90125-8 · Cited by 52
Hereditary Hypertriglyceridemic Rat: A New Animal Model of Metabolic Alterations in Hypertension
Klimeś, I., Vraana, A., Kuneš, J., et al. (1995) · Blood Pressure · doi:10.3109/08037059509077585 · Cited by 52
Miatello, R. M. (2001) · American Journal of Hypertension · doi:10.1016/s0895-7061(01)02206-3 · Cited by 52
“Hyperinsulinemia could activate the sympathetic system, which in turn will elevate the BP.17 It has been also demonstrated that FFR showed an impaired response to endothelium-dependent vasodilators.18 In addition, changes in cardiovascular production of vasoactive agonist as well as changes in its receptor density hav…”
BackgroundInfluentialInsulin Resistance, Energy Balance and Sympathetic Nervous System Activity
Landsberg, L. (1990) · Clinical and Experimental Hypertension · doi:10.3109/10641969009073502 · Cited by 50
Self-citationInsulin. Its role in the thermic effect of glucose.
Christin, L., Nacht, C. A., Vernet, O., Ravussin, E., Jéquier, E., & Acheson, K. J. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112497 · Cited by 50
Changes in blood pressure and plasma catecholamine levels during prolonged hyperinsulinemia
Kern, W., Peters, A., Jan Born, A., Fehm, H. L., & Schultes, B. (2005) · Metabolism · doi:10.1016/j.metabol.2004.10.005 · Cited by 50
Exercise Training in Obese Diabetic Patients
Zierath, J. R., & Wallberg‐Henriksson, H. (1992) · Sports Medicine · doi:10.2165/00007256-199214030-00004 · Cited by 51
Insulin treatment and cardiovascular disease; friend or foe? A point of view
Muis, M. J., Bots, M. L., Grobbee, D. E., & Stolk, R. P. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01416.x · Cited by 52
“Short-term hyperinsulinaemia, with a distinct dose–response relationship, results in vasoconstriction by sympathetic activation [44–46].”
Insulin Enhances Endothelial α 2 -Adrenergic Vasorelaxation by a Pertussis Toxin Mechanism
Lembo, G., Iaccarino, G., Vecchione, C., Barbato, E., Morisco, C., Monti, F., Parrella, L., & Trimarco, B. (1997) · Hypertension · doi:10.1161/01.hyp.30.5.1128 · Cited by 51
Sympathovagal Balance, Nighttime Blood Pressure, and QT Intervals in Normotensive Obese Women
Esposito, K., Marfella, R., Gualdiero, P., Carusone, C., Pontillo, A., Giugliano, G., Nicoletti, G., & Giugliano, D. (2003) · Obesity Research · doi:10.1038/oby.2003.93 · Cited by 51
Selective impairment of glucose storage in human sepsis
Saeed, M., Carlson, G., Little, R., & Irving, M. H. (1999) · British journal of surgery · doi:10.1046/j.1365-2168.1999.01140.x · Cited by 50
Effect of age on insulin stimulation of sympathetic nervous system activity in man
Minaker, K. L., Rowe, J. W., Young, J. B., Sparrow, D., Pallotta, J. A., & Landsberg, L. (1982) · Metabolism · doi:10.1016/0026-0495(82)90001-4 · Cited by 51
Self-citationEffect of an Insulin Sensitizer, Pioglitazone, on Hypertension in Fructose-Drinking Rats
Suzuki, M., Chisako, N., Odaka, H., & Ikeda, H. (1997) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.74.297 · Cited by 52
Insulin, Prostaglandins, and the Pathogenesis of Hypertension
Axelrod, L. (1991) · Diabetes · doi:10.2337/diab.40.10.1223 · Cited by 52
“Second, insulin increases sympathetic nervous system activity in humans (64), and resistance to the action of insulin on the sympathetic nervous system does not appear to develop in obese subjects (9,14).”
BackgroundSchipke, J. D., Friebe, R., & Gams, E. (2006) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2006.01.023 · Cited by 49
“200 IU) helped improving recovery of contractile function [16,44].”
BackgroundAnteroventral third ventricle lesions abolish lumbar sympathetic responses to insulin.
Muntzel, M., Beltz, T., Mark, A. L., & Johnson, A. K. (1994) · Hypertension · doi:10.1161/01.hyp.23.6.1059 · Cited by 48
Kaufman, L. N., Young, J. K., & Landsberg, L. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112336 · Cited by 49
Self-citationRavussin, É., & Bogardus, C. (1982) · Life Sciences · doi:10.1016/0024-3205(82)90040-6 · Cited by 48
The enigma of insulin resistance and hypertension
O’Hare, J. A. (1988) · The American Journal of Medicine · doi:10.1016/0002-9343(88)90273-2 · Cited by 48
A Potential Mechanism Predisposing to Body Weight Gain
Spraul, M., Ravussin, É., Fontvieille, A. M., Rising, R., Larson, D. E., & Anderson, E. A. (1993) · Cited by 49
Fertility in Polycystic Ovary Syndrome
Patel, S. M., & Nestler, J. E. (2006) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2005.09.005 · Cited by 48
Central Insulin Regulates Heart Rate and Arterial Blood Flow
Cabou, C., Cani, P. D., Campistron, G., Knauf, C., Mathieu, C., Sartori, C. S., Amar, J., Scherrer, U., & Burcelin, R. (2007) · Diabetes · doi:10.2337/db07-0115 · Cited by 48
“In addition to these peripheral actions, insulin is also a strong activator of the sympathetic autonomic nervous system (ANS) (7, 8).”
InfluentialXiang, A. H., Azen, S. P., Raffel, L. J., Tan, S., Li, C., Diaz, J., Toscano, E., Henderson, P. C., Hodis, H. N., Hsueh, W. A., et al. (2001) · Circulation · doi:10.1161/01.cir.103.1.78 · Cited by 48
Effects of insulin on the cardiac autonomic nervous system in insulin-resistant states
Paolisso, G., Manzella, D., Rizzo, M. R., et al. (2000) · Clinical Science · doi:10.1042/cs0980129 · Cited by 48
The hypertriglyceridemic rat as a genetic model of hypertension and diabetes
Stolba, P., Dobešová, Z., Hušek, P., et al. (1992) · Life Sciences · doi:10.1016/0024-3205(92)90482-5 · Cited by 48
Dual effect of insulin on plasma volume and transcapillary albumin transport
Hilsted, J., & Christensen, N. J. (1992) · Diabetologia · doi:10.1007/bf00402539 · Cited by 48
“Plasma noradrenaline levels increased, however, even when the blood glucose concentration remained high or unchanged [4-6].”
BackgroundInsulin resistance and cardiovascular complications in patients with essential hypertension
Kamide, K., Nagano, M., NAKANO, N., YOSHIKAGE, Y., KOBAYASHI, R., Rakugi, H., Higaki, J., & Ogihara, T. (1996) · American Journal of Hypertension · doi:10.1016/s0895-7061(96)00263-4 · Cited by 47
Kopp, W. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.1037750 · Cited by 60
Familial Hypertension, Insulin, Sympathetic Activity, and Blood Pressure Elevation
Masuo, K., Mikami, H., Ogihara, T., & Tuck, M. L. (1998) · Hypertension · doi:10.1161/01.hyp.32.1.96 · Cited by 47
1 Growth hormone deficiency and cardiovascular risk
Hew, F. L., O'Neal, D. N., Kamarudin, N., ALFORD, F. P., & Best, J. D. (1998) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(98)80018-9 · Cited by 46
Insulin and renal sodium retention in hypertension-prone men.
Endre, T., Mattiasson, I., Berglund, G., & Hulthén, U. L. (1994) · Hypertension · doi:10.1161/01.hyp.23.3.313 · Cited by 47
Hand, M. S., Armstrong, P., & Allen, T. A. (1989) · Veterinary Clinics of North America Small Animal Practice · doi:10.1016/s0195-5616(89)50055-x · Cited by 47
Preventing and Managing Cardiometabolic Risk: The Logic for Intervention
Pereira, M. A., Kottke, T. E., Jordan, C. O., O’Connor, P. J., Pronk, N. P., & Carreón, R. (2009) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph6102568 · Cited by 47
“Additionally, the reductions in hyperinsulinemia and abdominal fat associated with exercise may reduce blood pressure through decreased sodium retention and reduced sympathetic nervous system stimulation [58-61].”
BackgroundValensi, P. E., Chiheb, S., & Fysekidis, M. (2013) · Diabetologia · doi:10.1007/s00125-013-2909-x · Cited by 41
Braffett, B. H., Dagogo-Jack, S. E., Bebu, I., Sivitz, W. I., Larkin, M., Kolterman, O., & Lachin, J. M. (2019) · Diabetes Care · doi:10.2337/dc18-1574 · Cited by 46
“ity, with a resulting increase in pulse rate (31).”
BackgroundDoyle, P., Cusin, I., Rohner‐Jeanrenaud, F., & Jeanrenaud, B. (1995) · Brain Research · doi:10.1016/0006-8993(95)00402-c · Cited by 46
Role of sympathetic activity in blood pressure reduction with low calorie regimen.
Kushiro, T., Kobayashi, F., Osada, H., Tomiyama, H., Satoh, K., Otsuka, Y., Kurumatani, H., & Kajiwara, N. (1991) · Hypertension · doi:10.1161/01.hyp.17.6.965 · Cited by 45
Acute hyperinsulinemia induces sodium retention and a blood pressure decline in diabetes mellitus.
Gans, R. O. B., Bilo, H. J. G., Nauta, J. J. P., Heine, R. J., & Donker, A. J. M. (1992) · Hypertension · doi:10.1161/01.hyp.20.2.199 · Cited by 45
Seljeflot, I., Moan, A., Kjeldsen, S. E., Sandvik, E., & Arnesen, H. (1996) · Hypertension · doi:10.1161/01.hyp.27.6.1299 · Cited by 44
Klein, S., Jahoor, F., Wolfe, R. R., & Stuart, C. A. (1992) · Metabolism · doi:10.1016/0026-0495(92)90173-8 · Cited by 41
Bergholm, R., Westerbacka, J., Vehkavaara, S., Seppälä‐Lindroos, A., Goto, T., & Yki-Järvinen, H. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.3.7307 · Cited by 49
Rooney, D. P., Edgar, D., Sheridan, B., Atkinson, A. B., & Bell, P. M. (1991) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1991.tb01391.x · Cited by 44
Relative Glucose Tolerance and Subsequent Development of Hypertension in Pregnancy
Innes, K. E., Wimsatt, J., & McDuffie, R. S. (2001) · Obstetrics and Gynecology · doi:10.1097/00006250-200106000-00008 · Cited by 44
Enhanced insulin response relates to acetylcholine-induced vasoconstriction in vasospastic angina
Shimabukuro, M., Shinzato, T., Higa, S., et al. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)00381-y · Cited by 44
“vnsomotor tone through sympathetic nerve activation (14,15), hypertrophic effects on smooth muscle ceils (l&17) or modification of intracellular cation metabolism (18-20).”
BackgroundArcuate nucleus injection of an anti-insulin affibody prevents the sympathetic response to insulin
Luckett, B. S., Frielle, J., Wolfgang, L., & Stocker, S. D. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00081.2013 · Cited by 43
Meta-inflammation and cardiometabolic disease in obesity: Can heat therapy help?
Ely, B. R., Clayton, Z. S., McCurdy, C. E., Pfeiffer, J. D., & Minson, C. T. (2017) · Temperature · doi:10.1080/23328940.2017.1384089 · Cited by 46
Hypoglycemia counterregulation in elderly humans: relationship to glucose levels
Ortiz-Alonso, F. J., Gałecki, A. T., Herman, W. H., Smith, M. J., Jacquez, J. A., & Halter, J. B. (1994) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1994.267.4.e497 · Cited by 42
Is the insulin resistance syndrome the price to be paid to achieve body weight stability?
Tremblay, A., Boulé, N. G., Doucet, É., & Woods, S. C. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0803019 · Cited by 44
Watanabe, K., Sekiya, M., Tsuruoka, T., Funada, J., Kameoka, H., Miyagawa, M., & Kohara, K. (1999) · Journal of Hypertension · doi:10.1097/00004872-199917080-00016 · Cited by 43
Bezafibrate reduces heart rate and blood pressure in patients with hypertriglyceridemia
Jonkers, I. J. A. M., de Man, F. H. A. F., van der Laarse, A., Frölich, M., Leuven, J. A. G., Kamper, A. M., Blauw, G. J., & Smelt, A. H. M. (2001) · Journal of Hypertension · doi:10.1097/00004872-200104000-00012 · Cited by 42
Lipolysis during abdominal surgery.
Felländer, G., Nordenström, J., Tjäder, I., et al. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.78.1.8288698 · Cited by 42
Mikhail, N. E., & Tuck, M. L. (2000) · Current Hypertension Reports · doi:10.1007/s11906-000-0074-3 · Cited by 42
Racial and ethnic modifiers of the salt-blood pressure response.
Flack, J. M., Ensrud, K. E., Mascioli, S. R., Launer, C. A., Svendsen, K. H., Elmer, P. J., & Grimm, R. H. (1991) · Hypertension · doi:10.1161/01.hyp.17.1_suppl.i115 · Cited by 41
Landsberg, L., & Young, J. B. (1985) · Springer eBooks · doi:10.1007/978-1-4684-4817-7_6 · Cited by 42
Self-citationStimulation of thermogenesis in men after combined glucose-long-chain triglyceride infusion
Thiébaud, D., Acheson, K. J., Schutz, Y., Felber, J. P., Golay, A., DeFronzo, R. A., & Jéquier, E. (1983) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/37.4.603 · Cited by 42
The complex interaction between overweight, hypertension, and sympathetic overactivity
Feldstein, C. A., & Julius, S. (2009) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2009.10.001 · Cited by 42
Nemoto, S., Kobayashi, T., Taguchi, K., Matsumoto, T., & Kamata, K. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00178.2011 · Cited by 40
Asmar, A., Simonsen, L., Asmar, M., Madsbad, S., Holst, J. J., Frandsen, E., Moro, C., Sørensen, C. M., Jonassen, T. E. N., & Bülow, J. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00518.2015 · Cited by 41
Fehlert, E., Willmann, K., Fritsche, L., Linder, K., Husin, H. M., Schleger, F., Weiss, M., Kiefer‐Schmidt, I., Brucker, S. Y., Häring, H., et al. (2016) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.14474 · Cited by 44
Metadata
- Authors
- Rowe, J. W., Young, J. B., Minaker, K. L., Stevens, A. L., Pallotta, J., & Landsberg, L.
- Affiliations
- Harvard University (US)
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 1981-03-01
- Volume
- 30
- Issue
- 3
- Pages
- 219-225
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2111038792
- Cited by
- 1,143
- References
- 0
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 5 · 2023: 15 · 2022: 8 · 2021: 8 · 2020: 9 · 2019: 13 · 2018: 15 · 2017: 20 · 2016: 19 · 2015: 13 · 2014: 19 · 2013: 15 · 2012: 14
- FWCI
- 23.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Keywords
- insulin, glucose infusion, sympathetic activity, plasma norepinephrine, hyperinsulinemia, hyperglycemia, hyperinsulinemic-euglycemic clamp, pulse pressure, blood pressure, heart rate, carbohydrate metabolism, young men, dietary sucrose
- MeSH terms
- Adolescent, Adult, Blood Glucose, Blood Pressure, Glucose, Humans, Insulin, Kinetics, Male, Norepinephrine, Pulse, Sympathetic Nervous System
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review